Aventyn and BMS Hospital Trust Announce mHealth Center

Provides Remote Patient Monitoring and Care Management Services for At-risk Heart Failure Patients with “Vitalbeat”, a Specially Designed Patient Adherence and Monitoring System Using Standard Mobile Medical Technology


WLSA Convergence Summit, San Diego and Bangalore, India – May 23, 2012 Aventyn Inc., an innovative provider of remote patient monitoring and chronic disease management solutions, and BMS Hospital Trust a charitable hospital trust announced the formation of the mHealth Center in Bangalore, India. This announcement was made at the annual WLSA Convergence Summit being held in San Diego.


Heart failure is a common cardiovascular problem which is increasing in both prevalence and incidence globally and is associated with substantial morbidity and mortality. Management of heart failure patients is complex and has become a priority world over. Effective methods to keep heart failure patients out of the hospital are essential, both in the interests of the patient’s health, as well as to reduce the burden on the health care system.


Coronary heart disease (CHD) is the leading cause of death in India as well as worldwide. The estimate of total years of life lost due to total cardiovascular disease among the India population aged 35- 64 are higher than comparable countries such as Brazil and China and are predicted to increase from 2000 to 2030, when the differences may become more marked. The economic cost for India is estimated to be in the range of $8.7 billion in 1998 international dollars in 2005 due to CHD and co-morbidities. These estimates increase to $54 billion 1998 international dollars by 2015*. The World Health Organization (WHO) recommends a comprehensive and integrated approach as the means to preventing and controlling CHD. A rational and sustainable approach requires care coordination in identifying at-risk patients, design personalized strategy for vitals monitoring, promotes diet and medication adherence combined with the right education. The new mHealth Center will focus on deploying innovative solutions where these costs are possible to avoid, utilizing patient-centric mobile health monitoring solutions like Vitalbeat from Aventyn for remote chronic disease management.


The newly announced mHealth Center at the BMS Hospital Trust is part of the Aventyn Health Innovation Ecosystem launched in February 2012. Together with its global strategic partners, Aventyn’s collaboration with the Trust leverage innovative health technologies. The mHealth Center will be dedicated to using clinical evidence based solutions developed by Aventyn sponsored mhealth clinical studies to provide scalable, low cost mobile patient monitoring plans for improved chronic health care and solutions to fight long term disease.


The BMSHT and Aventyn Health Innovation Ecosystem continue to promote health through educational conferences and webinars for sharing training materials and resources. The Innovation Ecosystem help providers, payors and partner companies engage in information sharing and effectively implement practical, globally scalable mobile medical technology solutions.


About BMS Hospital Trust

BMS Hospital Trust was established in 1991in Bangalore, India by renowned philanthropist B.S. Narayan and is an affiliate of BMS Education Trust. The sole objective of the Trust was to start a general hospital for providing free health care services to the economically deprived. The trust has a vision to further develop its proliferating health care facilities with new technologies and services to provide cost effective and efficient healthcare.


About Vitalbeat™

Vitalbeat is a mobile remote patient monitoring and integrated chronic disease management system. Vitalbeat was developed for Phase 1 of the Remote-HF international, multi-center clinical study conducted at; Vivus-BMJ Heart Centre and Narayana Hrudayalaya in Bangalore, India, Karolinska University Hospital at Solna in Sweden, Saint Francis Hospital, Roslyn, New York and Winthrop-University Hospital, Mineola, New York in the USA. Mobile devices enabled patients and clinicians in the study to stay connected and informed using the Vitalbeat remote patient monitoring and chronic disease management system. This personalized patient software solution was tested for remotely monitoring heart failure patients and securely sharing patient vital sign information with clinicians to care for patients recruited in the study. The trial is registered in the United States FDA clinical trials registration site under NCT01430936. The two phase trial is sponsored by Aventyn in collaboration with BMS Hospital Trust in India; AT&T Healthcare, University of California and Zephyr Technology in the USA. Phase 2 of the trial is a structured two-year study conducted in collaboration with pharma and life science companies, wearable sensor-based medical device companies and global cloud, mobile service providers.


About Wireless Life Sciences Alliance (WLSA)

The Wireless Life Sciences Alliance (WLSA) is a trade organization for global wireless and mobile technology innovators, scientists, physicians, policy makers, service providers, and investors. The WLSA is committed to accelerating the adoption of connected health to improving health and wellness for consumers and caregivers while creating value for all sectors of the life sciences and technology ecosystem. WLSA members and partners are using wireless health innovations to simplify the management of chronic conditions, prevent disease, and improve lives around the world.


About Aventyn Inc.

Aventyn Inc. is an early stage health technology company seamlessly connecting clinicians and patients with our secure core to cloud clinical information processing platform for improved quality of life. Our CLIP«Care EMR solutions with CareLock™ health information security and integrated wireless bio-sensor capability enable continuity of care anytime, anywhere and anyplace. Vitalbeat–Integrated Chronic Disease Management™ patient personalized solutions are tailored for home and remote monitoring. Healthcare providers, insurance payers and pharma-lifescience companies use our patient personalized platform along with our medical device partners to document baseline patient chronic conditions, mobile patient monitoring, and population care management with preventive and wellness education. We offer bundled and per patient per month subscription solutions with strategic provider and payer partners. Aventyn UK Ltd. and Aventyn India are wholly owned subsidiaries of Aventyn Inc., USA.


CONTACT: Aventyn Inc.                      Aventyn India

Puja Chandler                                       Srinidhi C. N.

Email: puja@aventyn.com                      Email: srini@aventyn.com

Phone: +1.858.232.2698                        Phone: +91 (0) 80 2667 2547 (CLIP)



Magnus Gunnarsson

Email: magnus@aventyn.com

Phone: +1.858.344.6172


SOURCE: Aventyn Inc. *Other names, trademarks and brands are properties of their respective owners.

* CORONARY HEART DISEASE IN INDIA, Mark D Huffman, MD, MPH Northwestern University Feinberg School of Medicine, Chicago, USA,Centre for Chronic Disease Control, New Delhi, India


Home | AboutProductsSolutionsTrialsPartners | NewsContact     Copyrightę 2004-2012 Aventyn, Inc. All Rights Reserved